The total value of sales is less than 0.01% of market cap, indicating routine portfolio management rather than a signal of distress. Monitor next earnings report for any changes in fundamentals, but no immediate concern is warranted.
Price Chart
Executive Summary
Four insiders at United Therapeutics, including CEO Martine Rothblatt and CFO James Edgemon, conducted open-market share sales totaling $1.13 million over a 7-day period, following derivative exercises. The net direction is selling, with the largest sale by director Christopher Patusky.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold $143K, CFO James Edgemon sold $298K, EVP Paul Mahon sold $115K, and Director Christopher Patusky sold $579K in open-market transactions.
- All insiders also exercised stock options or derivatives, including non-cash transactions at $0 strike price, which are routine and non-material.
- Total open-market sales: $1.13M, representing approximately 0.004% of the company's $25.8B market cap — well below the 0.1% threshold for materiality.
- Sales occurred at prices between $573.91 and $578.88 per share, consistent with recent trading levels.
Financial Impact
$1.13 million in open-market share sales
Risk Factors
- Perception risk if media highlights CEO/CFO sales without context
- Potential for short-term sentiment pressure if interpreted as lack of confidence
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1776717516029 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access